Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check17 days agoChange DetectedThe site footer’s revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision: v3.7.0 is added to the page metadata. A substantial block of location names and study document items was removed, altering the displayed list of participating sites and available documents for the study.SummaryDifference25%

- Check66 days agoChange DetectedRevision: v3.6.6 was added and Revision: v3.6.5 was removed. This indicates a minor site version update with no user-facing content changes.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.